The RESPLASH Study
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Tulane University
- Study ID
- NCT06880562
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Splanchnic Nerve Denervation — DEVICECatheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation
- Renal Denervation Only — DEVICECatheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation
Study Details
To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: CDN of Renal arteries ArmCatheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation
- Experimental: CND of Renal Arteries and Splanchnic Nerves ArmCatheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation
Primary Outcome Measure
Change in office systolic and diastolic blood pressure [ Time Frame: Baseline, 3 months ]
Central Contacts
- Chris Wang, MS504-988-3065
- Suzanne Bowers, RN, BSN504-988-2030
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| East Jefferson General Hospital | New Orleans | Louisiana | 70006 | Jose Wiley, MD, MPH, FACC, FACP, FSCAI (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Orleans, LA
By condition
By specialty
By research site
Related Studies
- Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant HypertensionRecruiting · DeepQure Inc. · Orange, California